Erythropoietin in Traumatic Brain Injury (EPO-TBI)
Status:
Completed
Trial end date:
2015-05-01
Target enrollment:
Participant gender:
Summary
This study seeks to determine if erythropoietin alpha (EPO) administered to adult critical
care patients with moderate or severe traumatic brain injury improves neurological function
assessed at six months after injury.
Phase:
Phase 3
Details
Lead Sponsor:
Australian and New Zealand Intensive Care Research Centre
Collaborators:
Australian and New Zealand Intensive Care Society Clinical Trials Group Monash University National Health and Medical Research Council, Australia